FBLG logo

FibroBiologics, Inc. Common Stock

FBLG
Healthcare|Biotechnology|US
$0.98
+0.02 (+2.39%)
DCF Value
$0.73
Tangible Book / Share
$1.23
Cash / Share
$0.93
Next Earnings Report
Nov 13, 2026
EPS est. -$0.63
Financing Filings (last 12 months)
11
Shelf registrations / offering prospectuses — latest Jul 16, 2026 (424B3). Possible dilution.

Upcoming Data Readouts (0)

No upcoming completion dates found in active trials.

Recent Press Releases

FibroBiologics Announces Grant of European Patent for Fibroblast Delivery of Tumor Inhibitory Agents
Nov 5, 2026 · PRNewsWire
FibroBiologics Presents Preclinical Data on Fibroblast Spheroid-Derived Chondrocyte Spheroids for Degenerative Disc Disease at the North American Spine Society 2026 Annual Meeting
Oct 19, 2026 · PRNewsWire
FibroBiologics Announces Australian Patent Accepted for Cellular Blend for the Regeneration of Chondrocytes and Cartilage Cells in Degenerated Spinal Discs
Oct 14, 2026 · PRNewsWire
FibroBiologics Files Patent Application for Technology Designed to Produce GLP-1 and Other Therapeutic Peptides Inside the Body
Oct 7, 2026 · PRNewsWire
FibroBiologics Announces Grant of European Patent for Methods of Enhancing Fibroblast Therapeutic Activity
Sep 29, 2026 · PRNewsWire
FibroBiologics Announces Closing of $0.5 Million Private Placement with Chief Scientific Officer
Sep 17, 2026 · PRNewsWire
FibroBiologics Announces Issuance of New U.S. Patent for the Therapeutic Use of Fibroblasts in Wound Healing
Sep 3, 2026 · PRNewsWire
FibroBiologics Announces Issuance of New U.S. Patent for the Treatment of Degenerative Disc Disease Using Fibroblast Conditioned Media
Sep 1, 2026 · PRNewsWire
FibroBiologics Releases Third Batch of CYWC628 Drug Product for Phase 1/2 Diabetic Foot Ulcer Clinical Trial
Aug 27, 2026 · PRNewsWire
FibroBiologics Regains Compliance with Nasdaq Trading Rules
Aug 26, 2026 · PRNewsWire

SEC Filings (100)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Oct 19, 2026EFFECTDocumentIndex
Oct 19, 2026EFFECTDocumentIndex
Oct 13, 2026POS AMDocumentIndex
Oct 13, 2026POS AMDocumentIndex
Oct 13, 2026DDocumentIndex
Oct 8, 20268-KMaterial eventDocumentIndex
Sep 18, 20268-KMaterial eventDocumentIndex
Sep 17, 2026SC 13DActivist / 5%+ stakeDocumentIndex
Sep 16, 2026DDocumentIndex
Sep 15, 20268-KMaterial eventDocumentIndex
Sep 9, 2026DEFA14AProxy / shareholder voteDocumentIndex
Aug 24, 20268-KMaterial eventDocumentIndex
Aug 14, 2026SC 13GPassive 5%+ stakeDocumentIndex
Jul 31, 202610-QQuarterly reportDocumentIndex
Jul 31, 2026DEF 14AProxy / shareholder voteDocumentIndex
Jul 24, 20268-KMaterial eventDocumentIndex
Jul 17, 2026PRE 14AProxy / shareholder voteDocumentIndex
Jul 16, 2026EFFECTDocumentIndex
Jul 16, 2026424B3Offering prospectusDocumentIndex
Jul 10, 2026S-3Shelf registrationDocumentIndex
Jul 9, 20268-KMaterial eventDocumentIndex
Jun 29, 2026DDocumentIndex
Jun 29, 20268-KMaterial eventDocumentIndex
Jun 23, 20268-KMaterial eventDocumentIndex
May 6, 20268-KMaterial eventDocumentIndex
May 6, 2026424B5Offering prospectusDocumentIndex
May 5, 20268-KMaterial eventDocumentIndex
May 5, 2026ARSAnnual report to holdersDocumentIndex
May 5, 2026DEFA14AProxy / shareholder voteDocumentIndex
May 5, 2026DEF 14AProxy / shareholder voteDocumentIndex
May 1, 2026424B5Offering prospectusDocumentIndex
May 1, 20268-KMaterial eventDocumentIndex
Apr 30, 202610-QQuarterly reportDocumentIndex
Apr 22, 2026PRE 14AProxy / shareholder voteDocumentIndex
Apr 20, 20268-KMaterial eventDocumentIndex
Apr 17, 20268-KMaterial eventDocumentIndex
Apr 9, 20268-K/AMaterial eventDocumentIndex
Apr 9, 2026SC 13GPassive 5%+ stakeDocumentIndex
Apr 9, 20268-KMaterial eventDocumentIndex
Apr 3, 20268-KMaterial eventDocumentIndex